CD22 Antikörper (PE)
Kurzübersicht für CD22 Antikörper (PE) (ABIN6253874)
Target
Alle CD22 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- B-ly8, produces mouse IgG1 immunoglobulins directed against human CD22, molecular weight 130-140 kD
-
Isotyp
- IgG1
-
-
anti-CD22 Molecule (CD22) (AA 621-725) antibody
CD22 Reaktivität: Human FACS, WB, ELISA, IHC, ICC Wirt: Maus Monoclonal 2H1C4 unconjugated
anti-CD22 Molecule (CD22) (AA 621-725) antibodyCD22 Reaktivität: Human FACS, ELISA, ICC Wirt: Maus Monoclonal 1A3A11 unconjugated
anti-CD22 Molecule (CD22) (AA 52-178) antibodyCD22 Reaktivität: Human FACS, WB, ELISA, IHC, IF, Coat, StM Wirt: Maus Monoclonal BLCAM-1795 unconjugated
anti-CD22 Molecule (CD22) antibody (PE)CD22 Reaktivität: Human FACS, IFA Wirt: Maus Monoclonal RFB4 PE
anti-CD22 Molecule (CD22) (AA 52-178) antibodyCD22 Reaktivität: Human FACS, WB, ELISA, IHC, IF, Coat Wirt: Maus Monoclonal BLCAM-1796 unconjugated
anti-CD22 Molecule (CD22) antibodyCD22 Reaktivität: Human, Non-Human Primate FACS, WB, IP Wirt: Maus Monoclonal MEM-01 unconjugated
anti-CD22 Molecule (CD22) (AA 708-847) antibodyCD22 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-CD22 Molecule (CD22) (AA 52-178) antibodyCD22 Reaktivität: Human IHC Wirt: Kaninchen Monoclonal 022R unconjugated Recombinant Antibody
anti-CD22 Molecule (CD22) antibody (PE)CD22 Reaktivität: Human, Non-Human Primate FACS Wirt: Maus Monoclonal MEM-01 PE
anti-CD22 Molecule (CD22) antibody (FITC)CD22 Reaktivität: Human FACS Wirt: Maus Monoclonal IS7 FITC
-
-
Applikationshinweise
- immunohistochemistry on cytospots, immunohistochemistry on frozen tissue sections
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Lagerung
- 4 °C
-
-
- CD22 (CD22 Molecule (CD22))
-
Andere Bezeichnung
- CD22
-
Hintergrund
- Antigen distribution: CD22 is detected in the cytoplasm early in B cell development (late pro-B cell stage), appears on the cell surface simultaneously with surface IgD, and is found on most mature B cells. Expression is lost with terminal differentiation of B cells and is absent on plasma cells. Activation of B cells via surface Ig increases CD22 expression [1]. CD22 reacts with most B cell leukemias including Hairy Cell Leukemia (HCL) and B cell lymphomas. Cellular Expression: Pan B cells, (surface and cytoplasmatic staining).
Target
-
